ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis

NASDAQ:ESTA • VGG312491084

75.76 USD
-0.24 (-0.32%)
Last: Feb 23, 2026, 11:52 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, ESTA scores 3 out of 10 in our fundamental rating. ESTA was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of ESTA is average, but there are quite some concerns on its profitability. ESTA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ESTA had negative earnings in the past year.
  • In the past year ESTA has reported a negative cash flow from operations.
  • ESTA had negative earnings in each of the past 5 years.
  • In the past 5 years ESTA always reported negative operating cash flow.
ESTA Yearly Net Income VS EBIT VS OCF VS FCFESTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • The Return On Assets of ESTA (-24.62%) is comparable to the rest of the industry.
  • ESTA's Return On Equity of -509.99% is on the low side compared to the rest of the industry. ESTA is outperformed by 82.70% of its industry peers.
Industry RankSector Rank
ROA -24.62%
ROE -509.99%
ROIC N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESTA Yearly ROA, ROE, ROICESTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

  • The Gross Margin of ESTA (68.74%) is better than 76.22% of its industry peers.
  • In the last couple of years the Gross Margin of ESTA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for ESTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
ESTA Yearly Profit, Operating, Gross MarginsESTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ESTA has more shares outstanding
  • Compared to 5 years ago, ESTA has more shares outstanding
  • Compared to 1 year ago, ESTA has an improved debt to assets ratio.
ESTA Yearly Shares OutstandingESTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ESTA Yearly Total Debt VS Total AssetsESTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ESTA has an Altman-Z score of 2.70. This is not the best score and indicates that ESTA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ESTA has a better Altman-Z score (2.70) than 67.03% of its industry peers.
  • ESTA has a Debt/Equity ratio of 15.06. This is a high value indicating a heavy dependency on external financing.
  • ESTA has a worse Debt to Equity ratio (15.06) than 87.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 15.06
Debt/FCF N/A
Altman-Z 2.7
ROIC/WACCN/A
WACC9.79%
ESTA Yearly LT Debt VS Equity VS FCFESTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 3.33 indicates that ESTA has no problem at all paying its short term obligations.
  • ESTA has a Current ratio of 3.33. This is in the better half of the industry: ESTA outperforms 60.54% of its industry peers.
  • ESTA has a Quick Ratio of 2.10. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
  • ESTA's Quick ratio of 2.10 is in line compared to the rest of the industry. ESTA outperforms 56.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 2.1
ESTA Yearly Current Assets VS Current LiabilitesESTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ESTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.08%.
  • Looking at the last year, ESTA shows a very strong growth in Revenue. The Revenue has grown by 24.76%.
  • Measured over the past years, ESTA shows a quite strong growth in Revenue. The Revenue has been growing by 13.13% on average per year.
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.95% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ESTA will show a very strong growth in Revenue. The Revenue will grow by 26.34% on average per year.
EPS Next Y36.42%
EPS Next 2Y28.32%
EPS Next 3Y26.52%
EPS Next 5Y25.95%
Revenue Next Year26.54%
Revenue Next 2Y25.78%
Revenue Next 3Y26%
Revenue Next 5Y26.34%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESTA Yearly Revenue VS EstimatesESTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 200M 400M 600M
ESTA Yearly EPS VS EstimatesESTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ESTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ESTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESTA Price Earnings VS Forward Price EarningsESTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESTA Per share dataESTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • ESTA's earnings are expected to grow with 26.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.32%
EPS Next 3Y26.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ESTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ESTABLISHMENT LABS HOLDINGS

NASDAQ:ESTA (2/23/2026, 11:52:37 AM)

75.76

-0.24 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners105.4%
Inst Owner Change-2.89%
Ins Owners13.63%
Ins Owner Change0.2%
Market Cap2.20B
Revenue(TTM)190.97M
Net Income(TTM)-83.45M
Analysts82.86
Price Target84.92 (12.09%)
Short Float %17.14%
Short Ratio8.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.36%
Min EPS beat(2)-4.97%
Max EPS beat(2)29.69%
EPS beat(4)2
Avg EPS beat(4)-8.99%
Min EPS beat(4)-75.04%
Max EPS beat(4)29.69%
EPS beat(8)5
Avg EPS beat(8)-2.35%
EPS beat(12)8
Avg EPS beat(12)0.53%
EPS beat(16)9
Avg EPS beat(16)-21.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.05%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)1.38%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.38%
Revenue beat(8)3
Avg Revenue beat(8)-0.76%
Revenue beat(12)5
Avg Revenue beat(12)-1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.44%
PT rev (3m)12.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.86%
EPS NY rev (1m)0.31%
EPS NY rev (3m)11.08%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.53
P/FCF N/A
P/OCF N/A
P/B 134.55
P/tB 463
EV/EBITDA N/A
EPS(TTM)-2.84
EYN/A
EPS(NY)-1.05
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)-2.47
OCFYN/A
SpS6.57
BVpS0.56
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.62%
ROE -509.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.74%
FCFM N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 15.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.51%
Cap/Sales 3.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 2.1
Altman-Z 2.7
F-Score4
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)567.48%
Cap/Depr(5y)397.75%
Cap/Sales(3y)15.14%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
EPS Next Y36.42%
EPS Next 2Y28.32%
EPS Next 3Y26.52%
EPS Next 5Y25.95%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
Revenue Next Year26.54%
Revenue Next 2Y25.78%
Revenue Next 3Y26%
Revenue Next 5Y26.34%
EBIT growth 1Y-1.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.55%
EBIT Next 3Y44.22%
EBIT Next 5Y43.82%
FCF growth 1Y36.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.01%
OCF growth 3YN/A
OCF growth 5YN/A

ESTABLISHMENT LABS HOLDINGS / ESTA FAQ

What is the fundamental rating for ESTA stock?

ChartMill assigns a fundamental rating of 3 / 10 to ESTA.


What is the valuation status for ESTA stock?

ChartMill assigns a valuation rating of 1 / 10 to ESTABLISHMENT LABS HOLDINGS (ESTA). This can be considered as Overvalued.


How profitable is ESTABLISHMENT LABS HOLDINGS (ESTA) stock?

ESTABLISHMENT LABS HOLDINGS (ESTA) has a profitability rating of 1 / 10.


What is the expected EPS growth for ESTABLISHMENT LABS HOLDINGS (ESTA) stock?

The Earnings per Share (EPS) of ESTABLISHMENT LABS HOLDINGS (ESTA) is expected to grow by 36.42% in the next year.